Stocks · Health care · Wholesale-Drugs, Proprietaries & Druggists' Sundries

Cosmos Health Inc.

COSM Clue Score32
Greece Fiscal year ends December CIK 0001474167 Results filed 22 Oct 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Grigorios Siokas
30 Jul 2026
Chief Executive Officer
Buy
349,825
$0.20
$70.00K
Grigorios Siokas
29 Jul 2026
Chief Executive Officer
Buy
766,284
$0.18
$140.00K
Georgios Terzis
16 Jun 2026
Chief Financial Officer
Buy
168,135
$0.25
$42.00K
Grigorios Siokas
11 Jun 2026
Chief Executive Officer
Buy
218,447
$0.21
$45.00K
Grigorios Siokas
10 Jun 2026
Chief Executive Officer
Buy
701,447
$0.23
$160.00K
Grigorios Siokas
12 Feb 2026
Chief Executive Officer
Buy
388,532
$0.37
$145.00K
Grigorios Siokas
11 Feb 2026
Chief Executive Officer
Buy
291,262
$0.41
$120.00K
Grigorios Siokas
23 Jan 2026
Chief Executive Officer
Buy
90,325
$0.50
$45.00K
Grigorios Siokas
20 Jan 2026
Chief Executive Officer
Buy
353,321
$0.50
$175.00K
Grigorios Siokas
14 Jan 2026
Chief Executive Officer
Buy
493,495
$0.45
$220.00K
Grigorios Siokas
12 Jan 2026
Chief Executive Officer
Buy
113,185
$0.50
$57.00K
Grigorios Siokas
8 Jan 2026
Chief Executive Officer
Buy
156,190
$0.52
$81.00K
Grigorios Siokas
7 Jan 2026
Chief Executive Officer
Buy
124,880
$0.52
$65.00K
Grigorios Siokas
6 Jan 2026
Chief Executive Officer
Buy
133,953
$0.54
$72.00K
Grigorios Siokas
19 Dec 2025
Chief Executive Officer
Buy
88,314
$0.49
$43.00K
Grigorios Siokas
15 Dec 2025
Chief Executive Officer
Buy
168,472
$0.42
$70.00K
Grigorios Siokas
28 Nov 2025
Chief Executive Officer
Buy
76,360
$0.64
$49.00K
Grigorios Siokas
25 Nov 2025
Chief Executive Officer
Buy
55,732
$0.63
$35.00K
Grigorios Siokas
21 Nov 2025
Chief Executive Officer
Buy
56,080
$0.68
$38.00K
Grigorios Siokas
20 Nov 2025
Chief Executive Officer
Buy
51,315
$0.62
$32.00K
Grigorios Siokas
19 Nov 2025
Chief Executive Officer
Buy
61,614
$0.65
$40.00K

What was left out

Form 4 filings counted 29
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 0
Transactions with no price 0
Shares from compensation/vesting 3,648,407
History held since 10 Oct 2012